{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:10:01Z","timestamp":1768799401088,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.canrad.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T16:15:45Z","timestamp":1366128945000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Curieth\u00e9rapie du canal anal"],"prefix":"10.1016","volume":"17","author":[{"given":"P.","family":"Pommier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Hannoun-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Malet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Peiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2013.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0360-3016(89)90521-X","article-title":"Interstitial brachytherapy in the conservative treatment of anal and rectal cancers","volume":"17","author":"Papillon","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0010","first-page":"1039","article-title":"Chimioradioth\u00e9rapie des cancers du canal anal","volume":"92","author":"Ortholan","year":"2005","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2013.02.006_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Coordinating committee on cancer research","volume":"348","author":"UKCCCR1996","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2013.02.006_bib0020","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2013.02.006_bib0025","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0030","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0035","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD-03\u00a0trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2004.09.060","article-title":"Anal canal carcinoma: early-stage tumors<or=10mm (T1\u00a0or Tis): therapeutic options and original pattern of local failure after radiotherapy","volume":"62","author":"Ortholan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0360-3016(93)90421-Q","article-title":"Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison","volume":"27","author":"Allal","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0045","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2005.05.047","article-title":"Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer","volume":"63","author":"Chapet","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canrad.2007.02.001","article-title":"R\u00e9sultats \u00e0 long terme et facteurs pronostiques des carcinomes \u00e9pidermo\u00efdes du canal anal trait\u00e9s par irradiation","volume":"11","author":"Tournier-Rangeard","year":"2007","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.02.006_bib0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2010.02.055","article-title":"High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03\u00a0study)","volume":"80","author":"Hannoun-L\u00e9vi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12032-012-0402-x","article-title":"Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis","volume":"30","author":"Lestrade","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canrad.2011.05.015","article-title":"Faut-il adapter le traitement du carcinome du canal anal pour les patients \u00e2g\u00e9s\u00a0? Analyse r\u00e9trospective de la toxicit\u00e9 dans un centre fran\u00e7ais et revue de la litt\u00e9rature","volume":"16","author":"De Bari","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.02.006_bib0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brachy.2007.02.152","article-title":"Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma","volume":"6","author":"Oehler-J\u00e4nne","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2013.02.006_bib0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.canrad.2011.07.240","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers de l\u2019anus","volume":"15","author":"Peiffert","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.02.006_bib0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-717X-5-92","article-title":"Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer","volume":"5","author":"Vieillot","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0090","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":"Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.02.006_bib0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1748-717X-7-201","article-title":"Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?","volume":"7","author":"Dewas","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0100","article-title":"RTOG 0529: a phase 2\u00a0evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in carcinoma of the anal canal","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2006.03.013","article-title":"Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study","volume":"79","author":"Bruna","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0360-3016(00)01427-9","article-title":"Experience with split-course external beam irradiation+\/-chemotherapy and integrated Ir-192\u00a0high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal","volume":"49","author":"Kapp","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2008.04.011","article-title":"The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer","volume":"87","author":"Saarilahti","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","article-title":"The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy","volume":"50","author":"Weber","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0360-3016(03)00417-6","article-title":"Results of definitive irradiation in a series of 305\u00a0epidermoid carcinomas of the anal canal","volume":"56","author":"Deniaud-Alexandre","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.02.006_bib0130","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04\u00a0and 98-11","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0135","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2013.02.006_bib0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2010.04.013","article-title":"Impact of radiation dose on locoregional control and survival on squamous cell carcinoma of anal canal","volume":"95","author":"Engineer","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.02.006_bib0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.radonc.2007.12.004","article-title":"Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD-03)","volume":"87","author":"Tournier-Rangeard","year":"2008","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:20:45Z","timestamp":1761135645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321813000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1278321813000462"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2013.02.006","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curieth\u00e9rapie du canal anal","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}